D printing is used more and more frequently in medical devices and prosthetics, benefiting many patients. Recently, Aprecia announced that the US Food and Drug Administration (FDA) approved the company's prescription drug SPRITAM (levetiracetam, levetiracetam) instant tablets prepared by 3D printing technology for use in combination with other anti-epileptic drugs for adult or child patients. Partial seizures, myoclonic seizures, and primary generalized seizures.

According to Aprecia, SPRITAM uses aqueous fluids to bind multiple layers of the drug to create a long, water-soluble agent that allows the patient to dissolve quickly with a small amount of water.

According to Interview with Shi Lichen, head of the Beijing Dingchen Medical Management Consulting Center, according to the “Daily Economic News”: “3D printing drugs can simplify the production process, reduce pollution, and reduce waste of raw materials, which is an exploration of new production processes.” It is difficult to commercialize 3D printed drugs in China.